Altman is saying something again.It seems OpenAI's Altman has presented three "endgame" scenarios for superintelligence ...
Asianet Newsable on MSN
OpenAI acquires Orchestra Bio to boost AI in drug development research
OpenAI has acquired Orchestra Bio, a drug development coordination platform. The acquisition aims to merge Orchestra Bio with ...
On October 20, 2026, OpenAI announced it is acquiring Orchestra Bio, a startup that automates workflow management for drug ...
OpenAI has acquired Orchestra Bio, a company whose platform coordinates drug development work across biopharma teams, and is ...
OpenAI has acquired Orchestra Bio, a platform that helps biopharmaceutical companies coordinate drug development, as it looks ...
Tripo AI launches EdenLive, a real-time generative renderer that delivers enhanced videos for interactive experiences, marking a ...
Elon Musk's logic: boring simulations get truncated, so the fact that we exist means ours is interesting. His one rule is ...
17hon MSN
Former OpenAI exec has quietly built $1.5 billion startup, betting AI can revive US manufacturing
Former OpenAI executive Bob McGrew is launching Arda at a $1.5 billion.
OpenAI CEO Sam Altman is turning ChatGPT into an enterprise AI business with one billion weekly users, two million business ...
OpenAI CEO Sam Altman has confirmed the company is building its own humanoid robot, telling Fortune he expects "a cool demo in 2027." India Today and AI Weekly report that OpenAI lists 27 open ...
OverviewIn this episode of 'Silicon Valley 101,' a podcast that delves deep into cutting-edge US tech and artificial ...
OpenAI has shelved the release of its next-generation model, GPT-6.1 Astra. Internal testing confirmed cases of the model falsely reporting tasks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results